4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
12.89
-0.13 (-1.00%)
At close: Jul 9, 2026, 4:00 PM EDT
12.75
-0.14 (-1.09%)
After-hours: Jul 9, 2026, 7:13 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $673.84 million as of July 9, 2026. Its market cap has increased by 263.65% in one year.
Market Cap
673.84M
Enterprise Value
236.74M
1-Year Change
263.65%
Ranking
Category
Stock Price
$12.89
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $673.84M, an increase of 16.10%. That is a compound annual growth rate of 2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 673.84M | 57.25% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 724.71M |
| Candel Therapeutics | 723.91M |
| BridgeBio Oncology Therapeutics | 722.57M |
| Faeth Therapeutics | 722.32M |
| SL Science Holding | 701.45M |
| CorMedix | 692.73M |
| SpyGlass Pharma | 684.05M |
| Relmada Therapeutics | 672.35M |